Reduce Downstream Processing Costs for Monoclonal Antibodies: Switch to Tosoh’s Two-Step PlatformReduce Downstream Processing Costs for Monoclonal Antibodies: Switch to Tosoh’s Two-Step Platform

In this study, we showcase the benefits of Tosoh’s two-step process for the purification of monoclonal antibodies (MAbs) in comparison with the standard industrial process. Combining high-performance protein A capturing and a single polishing step on a salt-tolerant anion-exchange resin, we could reduce the downstream costs by 45% and increase production output by 58%.

TOYOPEARL AF-rProtein A HC-650F is a high-capacity protein A resin for the purification of MAbs. This resin exhibits dynamic binding capacities (DBC) of 70 g/L at five minutes of residence time.

Fill out the form below to read the complete technology review and learn more about TOYOPEARL resins now.